Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 25, 2022
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney DiseasePaul D Miller, Jonathan D Adachi, Ben-Hur Albergaria, et al.
Signal Transduction and Targeted Therapy|January 28, 2025
Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted studyFei Wang, Yongjiu Wang, Bin Xiong, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 22, 2026
Datopotamab deruxtecan in Chinese patients with heavily pretreated advanced or metastatic triple-negative breast cancer in the phase I/II TROPION-PanTumor02 studyTao Wang, Yuping Sun, Wenyan Chen, et al.
Chinese Medical Journal|November 25, 2025
Toremifene exerts chemopreventive effects against breast cancer through MTHFD1L suppression and ROS-mediated apoptosisLin Chen, Linfeng Zhao, Zhongbing Ma, et al.
Nature Communications|March 26, 2025
Large scale submarine groundwater discharge dominates nutrient inputs to China's coastTianyi Zhu, Shibin Zhao, Bochao Xu, et al.
Breast Cancer Research and Treatment|August 2, 2022
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center studyXinguang Wang, Zhaoqing Fan, Xing Wang, et al.
Therapeutic Advances in Medical Oncology|March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Iscience|July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world studyFengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapyAmina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Frontiers in Oncology|May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)Amina Maimaitiaili, Yijun Li, Na Chai, et al.
Pageof 24